GlaxoSmithKline (GSK)
Create an AlertGlaxoSmithKline EV / EBITDA TTM
GlaxoSmithKline EV / EBITDA TTM Chart
View EV / EBITDA TTM for GSK.
Start Your YCharts Pro Gold Membership.
GlaxoSmithKline Historical EV / EBITDA TTM Data
Pro Data ExportThere is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| June 18, 2013 | Go Pro |
| June 17, 2013 | Go Pro |
| June 14, 2013 | Go Pro |
| June 13, 2013 | Go Pro |
| June 12, 2013 | Go Pro |
| June 11, 2013 | Go Pro |
| June 10, 2013 | Go Pro |
| June 7, 2013 | Go Pro |
| June 6, 2013 | Go Pro |
| June 5, 2013 | Go Pro |
| June 4, 2013 | Go Pro |
| June 3, 2013 | Go Pro |
| May 31, 2013 | Go Pro |
| May 30, 2013 | Go Pro |
| May 29, 2013 | Go Pro |
| May 28, 2013 | Go Pro |
| May 24, 2013 | Go Pro |
| May 23, 2013 | Go Pro |
| May 22, 2013 | Go Pro |
| May 21, 2013 | Go Pro |
| May 20, 2013 | Go Pro |
| May 17, 2013 | Go Pro |
| May 16, 2013 | Go Pro |
| May 15, 2013 | Go Pro |
| May 14, 2013 | Go Pro |
| May 13, 2013 | Go Pro |
| May 10, 2013 | Go Pro |
| May 9, 2013 | Go Pro |
| May 8, 2013 | Go Pro |
| May 7, 2013 | Go Pro |
| May 6, 2013 | Go Pro |
| May 3, 2013 | Go Pro |
| May 2, 2013 | Go Pro |
| May 1, 2013 | Go Pro |
| April 30, 2013 | Go Pro |
| April 29, 2013 | Go Pro |
| April 26, 2013 | Go Pro |
| April 25, 2013 | Go Pro |
| April 24, 2013 | Go Pro |
| April 23, 2013 | Go Pro |
| April 22, 2013 | Go Pro |
| April 19, 2013 | Go Pro |
| April 18, 2013 | Go Pro |
| April 17, 2013 | Go Pro |
| April 16, 2013 | Go Pro |
| April 15, 2013 | Go Pro |
| April 12, 2013 | Go Pro |
| April 11, 2013 | Go Pro |
| April 10, 2013 | Go Pro |
| April 9, 2013 | Go Pro |
About EV / EBITDA
EV/EBITDA is the enterprise value of a company divided by its earnings before interest, taxes, depreciation and amortization. (EV/EBITDA)
EV/EBITDA answers the question "What is a company being valued per each dollar of EBITDA?" A high (low) EV/EBITDA mean the company is potentially overvalued (undervalued).
EV/Financial Metrics are often used by analysts to quickly look at a company's valuation multiples. All things being equal, the lower this ratio is, the better.
Other similar metrics include :
EV/Revenues: How much is each dollar of revenues worth to investors?
EV/EBIT : Or each dollar of EBIT?
EV/Free Cash Flow : Or each dollar of FCF?
For more information on evaluating valuation multiples similar to this, please see our original white paper research : Making Sense Of Valuation Multiples.
Learn More
View EV / EBITDA TTM for GSK.
Start Your YCharts Pro Gold Membership.
Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle.
YCharts Pro is only $49/month, and comes with a 14-day free trial.
Get Started NowAlready a YCharts Pro Gold Member? Sign in here.
GSK EV / EBITDA TTM Benchmarks
| Companies | |
|---|---|
| AstraZeneca | Go Pro |
| Merck | Go Pro |
| Eli Lilly and Company | Go Pro |
GSK EV / EBITDA TTM Rankings
| Overall |
83rd percentile 2848 of 16770 |
| Sector |
89th percentile 153 of 1408 in Healthcare |
| Industry |
82nd percentile 23 of 135 in Drug Manufacturers - Major |
GSK EV / EBITDA TTM Range, Past 5 Years
| Minimum | Go Pro | Mar 9 2009 |
| Maximum | Go Pro | Jan 4 2011 |
| Average | Go Pro |
